Figure 3.

Impact of FABP5 expression on prognostic significance of peroxisome proliferator-activated receptor γ (PPARγ) in PCa patients. Log-rank test of Kaplan–Meier patient survival curves was performed using MedCalc (version 14.12.0) and the cut-off point for stratifying the patient population with high or low levels of FABP5 and PPARγ mRNA was determined by receiver operating characteristic (ROC) analysis using recurrence status as a classification factor. The FABP5 and PPARγ mRNA levels and patient clinical records were obtained from cBioPortal (http://www.cbioportal.org/datasets) [44]. n, sample size; HR, hazard ratio; p, statistical significance level.